The global clinical trial supply management market is expected to grow at a CAGR of 7.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing number of clinical trials and growing demand for clinical trial supply management services.
The global clinical trial supply management market is segmented on the basis of type, application, and region. On the basis of type, it can be classified into software and services. On the basis of application, it can be classified into pharmaceuticals and biologics. On the basis of region, it can be classified into North America (NA), Latin America (LA), Europe (EU), Asia Pacific (APAC) and Middle East & Africa (MEA).
- Increasing number of clinical trials and growing demand for CROs are the major drivers for the growth of this market.
- Increasing number of mergers and acquisitions in the pharmaceutical industry is also driving the growth of this market.
- The increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases is also driving the growth of this market.
- Growing awareness about clinical trials among patients and healthcare providers will drive the growth in this market.
Industry Growth Insights published a new data on “Clinical Trial Supply Management Market”. The research report is titled “Clinical Trial Supply Management Market research by Types (Software, Services, Clinical Trial Supply Managemen), By Applications (Pharmaceutical, Biologics, Medical Device, Others), By Players/Companies SAP, Contract Pharma, Parexel, Almac Group, Catalent Pharma Solutions, Piramal Pharma Solutions, Klifo A/S., Nomeco A/S, Clinical Trial Supply Managemen”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Clinical Trial Supply Management Market Research Report
By Type
Software, Services, Clinical Trial Supply Managemen
By Application
Pharmaceutical, Biologics, Medical Device, Others
By Companies
SAP, Contract Pharma, Parexel, Almac Group, Catalent Pharma Solutions, Piramal Pharma Solutions, Klifo A/S., Nomeco A/S, Clinical Trial Supply Managemen
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
237
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Clinical Trial Supply Management Market Report Segments:
The global Clinical Trial Supply Management market is segmented on the basis of:
Types
Software, Services, Clinical Trial Supply Managemen
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical, Biologics, Medical Device, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- SAP
- Contract Pharma
- Parexel
- Almac Group
- Catalent Pharma Solutions
- Piramal Pharma Solutions
- Klifo A/S.
- Nomeco A/S
- Clinical Trial Supply Managemen
Highlights of The Clinical Trial Supply Management Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Software
- Services
- Clinical Trial Supply Managemen
- By Application:
- Pharmaceutical
- Biologics
- Medical Device
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Clinical Trial Supply Management Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Clinical trial supply management (CTSM) is a process that helps ensure the timely and accurate delivery of clinical trial supplies to study sites. It includes the identification of required supplies, procurement, tracking, and distribution. CTSM also ensures that all necessary safety precautions are taken during the handling and use of these supplies.
Some of the key players operating in the clinical trial supply management market are SAP, Contract Pharma, Parexel, Almac Group, Catalent Pharma Solutions, Piramal Pharma Solutions, Klifo A/S., Nomeco A/S, Clinical Trial Supply Managemen.
The clinical trial supply management market is expected to grow at a compound annual growth rate of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Clinical Trial Supply Management Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Clinical Trial Supply Management Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Clinical Trial Supply Management Market - Supply Chain
4.5. Global Clinical Trial Supply Management Market Forecast
4.5.1. Clinical Trial Supply Management Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Clinical Trial Supply Management Market Size (000 Units) and Y-o-Y Growth
4.5.3. Clinical Trial Supply Management Market Absolute $ Opportunity
5. Global Clinical Trial Supply Management Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Clinical Trial Supply Management Market Size and Volume Forecast by Type
5.3.1. Software
5.3.2. Services
5.3.3. Clinical Trial Supply Managemen
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Clinical Trial Supply Management Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Clinical Trial Supply Management Market Size and Volume Forecast by Application
6.3.1. Pharmaceutical
6.3.2. Biologics
6.3.3. Medical Device
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Clinical Trial Supply Management Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Clinical Trial Supply Management Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Clinical Trial Supply Management Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Clinical Trial Supply Management Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Clinical Trial Supply Management Demand Share Forecast, 2019-2026
9. North America Clinical Trial Supply Management Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Clinical Trial Supply Management Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Clinical Trial Supply Management Market Size and Volume Forecast by Application
9.4.1. Pharmaceutical
9.4.2. Biologics
9.4.3. Medical Device
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Clinical Trial Supply Management Market Size and Volume Forecast by Type
9.7.1. Software
9.7.2. Services
9.7.3. Clinical Trial Supply Managemen
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Clinical Trial Supply Management Demand Share Forecast, 2019-2026
10. Latin America Clinical Trial Supply Management Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Clinical Trial Supply Management Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Clinical Trial Supply Management Market Size and Volume Forecast by Application
10.4.1. Pharmaceutical
10.4.2. Biologics
10.4.3. Medical Device
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Clinical Trial Supply Management Market Size and Volume Forecast by Type
10.7.1. Software
10.7.2. Services
10.7.3. Clinical Trial Supply Managemen
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Clinical Trial Supply Management Demand Share Forecast, 2019-2026
11. Europe Clinical Trial Supply Management Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Clinical Trial Supply Management Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Clinical Trial Supply Management Market Size and Volume Forecast by Application
11.4.1. Pharmaceutical
11.4.2. Biologics
11.4.3. Medical Device
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Clinical Trial Supply Management Market Size and Volume Forecast by Type
11.7.1. Software
11.7.2. Services
11.7.3. Clinical Trial Supply Managemen
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Clinical Trial Supply Management Demand Share, 2019-2026
12. Asia Pacific Clinical Trial Supply Management Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Clinical Trial Supply Management Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Clinical Trial Supply Management Market Size and Volume Forecast by Application
12.4.1. Pharmaceutical
12.4.2. Biologics
12.4.3. Medical Device
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Clinical Trial Supply Management Market Size and Volume Forecast by Type
12.7.1. Software
12.7.2. Services
12.7.3. Clinical Trial Supply Managemen
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Clinical Trial Supply Management Demand Share, 2019-2026
13. Middle East & Africa Clinical Trial Supply Management Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Clinical Trial Supply Management Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Clinical Trial Supply Management Market Size and Volume Forecast by Application
13.4.1. Pharmaceutical
13.4.2. Biologics
13.4.3. Medical Device
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Clinical Trial Supply Management Market Size and Volume Forecast by Type
13.7.1. Software
13.7.2. Services
13.7.3. Clinical Trial Supply Managemen
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Clinical Trial Supply Management Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Clinical Trial Supply Management Market: Market Share Analysis
14.2. Clinical Trial Supply Management Distributors and Customers
14.3. Clinical Trial Supply Management Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. SAP
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Contract Pharma
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Parexel
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Almac Group
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Catalent Pharma Solutions
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Piramal Pharma Solutions
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Klifo A/S.
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Nomeco A/S
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Clinical Trial Supply Managemen
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
